The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 40.51%.However, over the last six months, we can see a
Monopar Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $1.73 on 02/23/24 and the lowest value was $0.27 on 11/27/23. 52-week price history of MNPR Stock Studying a stock’s 52-week price history, which includes
After-hours trading on Monday saw shares of Monopar Therapeutics Inc. (NASDAQ: MNPR) rise 8.78% to $2.23 following the release of encouraging clinical-trial data. What data has MNPR provided? Yesterday, Monopar Therapeutics (MNPR) published encouraging findings with MNPR-202 from its ongoing partnership with the National University
All rights reserved © 2024, Powered By Smart TechOne
